206 related articles for article (PubMed ID: 7569668)
1. Differences between pharmacokinetics and toxicokinetics.
Welling PG
Toxicol Pathol; 1995; 23(2):143-7. PubMed ID: 7569668
[TBL] [Abstract][Full Text] [Related]
2. Toxicokinetics/toxicodynamic correlations: goals, methods, and limitations.
Batra VK
Toxicol Pathol; 1995; 23(2):158-64. PubMed ID: 7569670
[TBL] [Abstract][Full Text] [Related]
3. Research tools for extrapolating the disposition and pharmacokinetics of nanomaterials from preclinical animals to humans.
Valic MS; Zheng G
Theranostics; 2019; 9(11):3365-3387. PubMed ID: 31244958
[TBL] [Abstract][Full Text] [Related]
4. Concomitant toxicokinetics: techniques for and interpretation of exposure data obtained during the conduct of toxicology studies.
Dahlem AM; Allerheiligen SR; Vodicnik MJ
Toxicol Pathol; 1995; 23(2):170-8. PubMed ID: 7569672
[TBL] [Abstract][Full Text] [Related]
5. Absorption, metabolism, and other factors that influence drug exposure in toxicology studies.
Mayer PR
Toxicol Pathol; 1995; 23(2):165-9. PubMed ID: 7569671
[TBL] [Abstract][Full Text] [Related]
6. A toxicity risk index, an index for warning idiosyncratic drug toxicity.
Morimoto M; Samizo K; Ohta S; Mizuma T
J Pharm Sci; 2013 Sep; 102(9):3447-50. PubMed ID: 23666879
[TBL] [Abstract][Full Text] [Related]
7. Issues related to the use of canines in toxicologic pathology--issues with pharmacokinetics and metabolism.
Tibbitts J
Toxicol Pathol; 2003; 31 Suppl():17-24. PubMed ID: 12597427
[TBL] [Abstract][Full Text] [Related]
8. Toxicokinetics in the National Toxicology Program.
Goehl TJ
NIDA Res Monogr; 1997; 173():273-304. PubMed ID: 9260193
[TBL] [Abstract][Full Text] [Related]
9. Toxicokinetic and toxicodynamic considerations when deriving health-based exposure limits for pharmaceuticals.
Reichard JF; Maier MA; Naumann BD; Pecquet AM; Pfister T; Sandhu R; Sargent EV; Streeter AJ; Weideman PA
Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S67-78. PubMed ID: 27224509
[TBL] [Abstract][Full Text] [Related]
10. Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment.
Dixit R; Riviere J; Krishnan K; Andersen ME
J Toxicol Environ Health B Crit Rev; 2003; 6(1):1-40. PubMed ID: 12587252
[TBL] [Abstract][Full Text] [Related]
11. Toxicokinetics in the evaluation of toxicity data.
Watanabe PG; Schumann AM; Reitz RH
Regul Toxicol Pharmacol; 1988 Dec; 8(4):408-13. PubMed ID: 3222482
[TBL] [Abstract][Full Text] [Related]
12. Multi-organ-on-a-chip for pharmacokinetics and toxicokinetic study of drugs.
Sung JH
Expert Opin Drug Metab Toxicol; 2021 Aug; 17(8):969-986. PubMed ID: 33764248
[No Abstract] [Full Text] [Related]
13. Pharmacokinetics and toxicokinetics of bio-pharmaceuticals: technical problems.
Kawai M
J Toxicol Sci; 1996 Dec; 21(5):535-7. PubMed ID: 9035067
[No Abstract] [Full Text] [Related]
14. Application of pharmacokinetics in drug safety evaluation.
Singhvi SM; Keim GR; Migdalof BH
Regul Toxicol Pharmacol; 1985 Mar; 5(1):3-17. PubMed ID: 3991931
[TBL] [Abstract][Full Text] [Related]
15. Auditing drug metabolism protocols, data, and reports.
Lucas G; Walls S
Qual Assur; 1994 Jun; 3(2):193-7. PubMed ID: 7804636
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view.
Shah RR
Xenobiotica; 1993 Nov; 23(11):1159-93. PubMed ID: 8310705
[TBL] [Abstract][Full Text] [Related]
17. Application of population pharmacokinetics for preclinical safety and efficacy studies.
Porzio S
Bioanalysis; 2013 Aug; 5(16):2053-69. PubMed ID: 23937139
[TBL] [Abstract][Full Text] [Related]
18. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
19. Basic principles of pharmacokinetics.
Benet LZ; Zia-Amirhosseini P
Toxicol Pathol; 1995; 23(2):115-23. PubMed ID: 7569664
[TBL] [Abstract][Full Text] [Related]
20. Drug toxicokinetics: scope and limitations that arise from species differences in pharmacodynamic and carcinogenic responses.
Monro A
J Pharmacokinet Biopharm; 1994 Feb; 22(1):41-57. PubMed ID: 8027948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
